The significant role of PB-CD11b+CX3CR1+ monocytes on PFS and OS in patients with newly diagnosed DLBCL might be attributed to the pro-angiogenic capacity of these cells. This evidence concerns the gene CX3CR1 and diffuse large B-cell lymphoma.